Prospects for Gene Therapy for Endocrine Malignancies

Christine Spitzweg, Ian D Hay, John C. Morris

Research output: Chapter in Book/Report/Conference proceedingChapter

Original languageEnglish (US)
Title of host publicationClinical Endocrine Oncology: Second Edition
PublisherBlackwell Publishing Ltd
Pages49-57
Number of pages9
ISBN (Print)9781405145848
DOIs
StatePublished - Jan 27 2009

Fingerprint

Immunomodulation
Genetic Therapy
Neoplasms

Keywords

  • Gene therapy approaches and thyroid cancer
  • Gene therapy for endocrine cancer-a new technology
  • Gene therapy in thyroid cancer
  • Immunomodulatory gene therapy
  • Inhibition of oncogenic RET signaling in medullary thyroid cancer
  • MUC1 promoter targetting NIS gene expression to ovarian and breast cancer
  • NIS gene therapy
  • Sodium iodide symporter (NIS) gene cloning and powerful new diagnostic and therapeutic genes

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Spitzweg, C., Hay, I. D., & Morris, J. C. (2009). Prospects for Gene Therapy for Endocrine Malignancies. In Clinical Endocrine Oncology: Second Edition (pp. 49-57). Blackwell Publishing Ltd. https://doi.org/10.1002/9781444300222.ch6

Prospects for Gene Therapy for Endocrine Malignancies. / Spitzweg, Christine; Hay, Ian D; Morris, John C.

Clinical Endocrine Oncology: Second Edition. Blackwell Publishing Ltd, 2009. p. 49-57.

Research output: Chapter in Book/Report/Conference proceedingChapter

Spitzweg, C, Hay, ID & Morris, JC 2009, Prospects for Gene Therapy for Endocrine Malignancies. in Clinical Endocrine Oncology: Second Edition. Blackwell Publishing Ltd, pp. 49-57. https://doi.org/10.1002/9781444300222.ch6
Spitzweg C, Hay ID, Morris JC. Prospects for Gene Therapy for Endocrine Malignancies. In Clinical Endocrine Oncology: Second Edition. Blackwell Publishing Ltd. 2009. p. 49-57 https://doi.org/10.1002/9781444300222.ch6
Spitzweg, Christine ; Hay, Ian D ; Morris, John C. / Prospects for Gene Therapy for Endocrine Malignancies. Clinical Endocrine Oncology: Second Edition. Blackwell Publishing Ltd, 2009. pp. 49-57
@inbook{ced636f4e319471d86188d959d78f122,
title = "Prospects for Gene Therapy for Endocrine Malignancies",
keywords = "Gene therapy approaches and thyroid cancer, Gene therapy for endocrine cancer-a new technology, Gene therapy in thyroid cancer, Immunomodulatory gene therapy, Inhibition of oncogenic RET signaling in medullary thyroid cancer, MUC1 promoter targetting NIS gene expression to ovarian and breast cancer, NIS gene therapy, Sodium iodide symporter (NIS) gene cloning and powerful new diagnostic and therapeutic genes",
author = "Christine Spitzweg and Hay, {Ian D} and Morris, {John C.}",
year = "2009",
month = "1",
day = "27",
doi = "10.1002/9781444300222.ch6",
language = "English (US)",
isbn = "9781405145848",
pages = "49--57",
booktitle = "Clinical Endocrine Oncology: Second Edition",
publisher = "Blackwell Publishing Ltd",

}

TY - CHAP

T1 - Prospects for Gene Therapy for Endocrine Malignancies

AU - Spitzweg, Christine

AU - Hay, Ian D

AU - Morris, John C.

PY - 2009/1/27

Y1 - 2009/1/27

KW - Gene therapy approaches and thyroid cancer

KW - Gene therapy for endocrine cancer-a new technology

KW - Gene therapy in thyroid cancer

KW - Immunomodulatory gene therapy

KW - Inhibition of oncogenic RET signaling in medullary thyroid cancer

KW - MUC1 promoter targetting NIS gene expression to ovarian and breast cancer

KW - NIS gene therapy

KW - Sodium iodide symporter (NIS) gene cloning and powerful new diagnostic and therapeutic genes

UR - http://www.scopus.com/inward/record.url?scp=84889272800&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84889272800&partnerID=8YFLogxK

U2 - 10.1002/9781444300222.ch6

DO - 10.1002/9781444300222.ch6

M3 - Chapter

SN - 9781405145848

SP - 49

EP - 57

BT - Clinical Endocrine Oncology: Second Edition

PB - Blackwell Publishing Ltd

ER -